There are multiple chapters near you. Select your preferred chapter.
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
Adicet Bio announced the first person with lupus nephritis (LN) has been dosed with ADI-001, an investigational allogeneic gamma delta CAR T cell therapy that targets B cells. The phase 1 study of ADI ...
The Lupus Foundation of America (LFA) is proud to honor two exceptional lupus researchers at the 2024 Evelyn V. Hess ...
Seattle Children’s announced they are now enrolling participants in the first CAR T cell clinical trial for children with ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to ...
A range of medications are available to help treat lupus nephritis (LN), each offering a specific role in managing the ...
The Lupus Foundation of America (LFA), along with numerous researchers funded by the Foundation, will present novel lupus discoveries as part of the American College of Rheumatology Convergence 2024 ...